2ND ANNUAL DRUG/DEVICE COMBINATION PRODUCTS SUMMIT 2019

December 4-5, 2019 | Czech Republic

The summit content and tentative schedule will be updated soon. Speaking sessions will be grouped according to similar themes into blocks and published upon finalizing the agenda, so please check back.

Spotlight

Pharmaceutical and life sciences companies are under intense pressure to introduce new products in an environment of escalating R&D costs, complex science, heightened regulatory scrutiny, and increased competition. The industry's traditional strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbusters worked well for shareholders for many years.


OTHER PAST CONFERENCES

4th International Conference on Alternative Medicine

July 15-16, 2022 | USA

Alternative & Integrative Medicine2022 is honored to extend an invitation to all notable individuals from around the world to the "4th International Conference on Alternative Medicine," which will be held as a Webinar on July 15-16, 2022.

World Drug Safety Congress Europe

September 27-29, 2022 | USA

The World Drug Safety Congress Europe is empowering patients, physicians, pharma, biotech and consumers to make the best drug safety decisions.

Pharmaceutics and Advanced Drug Delivery Systems

September 1-2, 2022 | Italy

4th International Conference on Pharmaceutics and Advanced Drug Delivery Systems will welcome you to Rome, Italy September 1-2, 2022.

80TH FIP WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES

September 18-22, 2022 | Spain

At this critical time, when the challenges presented by the COVID-19 pandemic are still current and on the minds of healthcare professionals, we must take the opportunity to create more comprehensive plans to better manage health crises that may be on the horizon.

Spotlight

Pharmaceutical and life sciences companies are under intense pressure to introduce new products in an environment of escalating R&D costs, complex science, heightened regulatory scrutiny, and increased competition. The industry's traditional strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbusters worked well for shareholders for many years.

resources